Medical devices, healthcare technology and the business of care
510(k) clearance · K263048

Syngo Carbon Space (VA4)

Siemens Healthineers AG · Decision date Sep 29, 2026

MEDTECHLEDGER EXPLANATIONK263048

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 29, 2026 for K263048, Syngo Carbon Space (VA4), submitted by Siemens Healthineers AG under 21 CFR 892.2050 (medical image management and processing system, Class II, product code LLZ, radiology). The public record lists the submission as a Traditional 510(k) received August 31, 2026 and reviewed by a third party. SESE denotes 510(k) clearance, not premarket approval.

The summary describes a software-only device for display, rendering and post-processing of medical data, installed on common IT hardware that is not part of the device. The listed predicate is Syngo Carbon Space (VA30A), cleared as K230561. The comparison table records a new version, simplified indications, removal of the "Diagnostic Workspace" term, and carving out the "Physician Access" option into a separate device, Syngo Carbon Enterprise Access. The record does not quantify performance testing or describe clinical evidence.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 29, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K263048
Regulatory pathway
510(k) premarket notification
Product code
LLZ
Decision code
SESE
Decision date
Sep 29, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Image Processing, Radiological.

Product code
LLZ
FDA device class
2

FDA decision timeline

  1. K263048 received

    Application receipt date recorded by FDA.

  2. K263048 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LLZ

Product / regulatory recordCompanyPathwayDecision dateSource
The Jacobs Institute510(k) clearanceNov 5, 2026FDA
Elevate Imaging, Inc.510(k) clearanceNov 4, 2026FDA
Canon Medical Informatics, Inc.510(k) clearanceOct 29, 2026FDA
Mim Software, Inc.510(k) clearanceOct 26, 2026FDA
Perception Vision Medical Technology Co., Ltd.510(k) clearanceOct 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Siemens Healthineers AG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Forchheim

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records